Back to Companies
UroGen Pharma Ltd.
URGNNasdaqCIK: 0001668243
Recent Form 4 activity at UroGen Pharma Ltd. (URGN) spans 36 filings across 10 insiders (all of them on the sell side). Purchases total $0 against $2.2M in sales — heavily weighted toward selling, for net sales of $2.2M. Schoenberg Mark (Chief Medical Officer) is the most active by dollar volume, and the single largest transaction was $699.8K by Belldegrun Arie. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$6.4M
Purchases
$0
Sales
$2.2M
Unique Insiders
10
Recent Insider Trades
36 loaded
| Jul 10 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $400.0K |
| Jun 24 | URGN UroGen Pharma Ltd. | Belldegrun Arie | Director | Award | $699.8K |
| Jun 24 | URGN UroGen Pharma Ltd. | WEN LEANA | Director | Award | $349.9K |
| Jun 24 | URGN UroGen Pharma Ltd. | Wildman Daniel George | Director | Award | $349.9K |
| Jun 24 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Award | $699.8K |
| Jun 24 | URGN UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Award | $349.9K |
| Jun 24 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $350.1K |
| Jun 24 | URGN UroGen Pharma Ltd. | Robinson James A. Jr. | Director | Award | $349.9K |
| Jun 9 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $142.6K |
| May 27 | URGN UroGen Pharma Ltd. | Robinson James A. Jr. | Director | Exercise | $0 |
| May 11 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $300.0K |
| Feb 27 | URGN UroGen Pharma Ltd. | Robinson James A. Jr. | Director | Exercise | $0 |
| Feb 4 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $145.2K |
| Feb 11 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $147.3K |
| Feb 3 | URGN UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | Award | $0 |
| Feb 3 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Exercise | $0 |
| Feb 19 | URGN UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Officer | Award | $0 |
| Dec 1 | URGN UroGen Pharma Ltd. | Robinson James A. Jr. | Director | Exercise | $0 |
| Dec 1 | URGN UroGen Pharma Ltd. | WEN LEANA | Director | Exercise | $0 |
| Dec 1 | URGN UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Exercise | $0 |
| Dec 1 | URGN UroGen Pharma Ltd. | Wildman Daniel George | Director | Exercise | $0 |
| Dec 1 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Exercise | $0 |
| Nov 20 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $250.0K |
| Oct 9 | URGN UroGen Pharma Ltd. | Degnan Chris | Chief Financial Officer | Sell | $37.1K |
| Sep 9 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $16.6K |
| Sep 9 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $29.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | WEN LEANA | Director | Award | $195.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | Holden Stuart | Director | Award | $195.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | Robinson James A. Jr. | Director | Award | $195.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | Belldegrun Arie | Director | Award | $390.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | Wildman Daniel George | Director | Award | $195.0K |
| Aug 27 | URGN UroGen Pharma Ltd. | BUTITTA CYNTHIA M | Director | Award | $195.0K |
| Aug 13 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $176.9K |
| Jul 30 | URGN UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Officer | Award | $0 |
| Jul 30 | URGN UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Sell | $144.0K |
| Jul 30 | URGN UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | Sell | $98.6K |
36 filings